Sign in / Join Now
ETFs & Funds
BUY at $6.60 Stop: 6.51, Loss: 3.7% Target T1: 8.16, Profit: 20.7%
Add a reply...
Latest StockTalks »
people get AMPE breaking news and analysis by email alert.
Get email alerts on AMPE »
Ampio Pharmaceuticals, Inc.
Get latest price
From other sites
Ampio Announces Accepted Publication Of The Clinical Trial Results Of Its Oral Drug, Optina™, Treatment Of Diabetic Macular Edema
at TheStreet (Oct 4, 2016)
Ampio Updates Clinical And Regulatory Activity
at TheStreet (Sep 29, 2016)
Ampio Reports Peer-Reviewed Publication On The Potential Use Of Ampion™ In New Clinical Indications
at TheStreet (Sep 8, 2016)
Ampio Reports Additional Peer-Reviewed Publication On Ampion™
at TheStreet (Aug 30, 2016)
Ampio Pharmaceuticals, Inc. Announces Pricing Of Registered Direct Offering
at TheStreet (Aug 29, 2016)